Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"

J Am Acad Dermatol. 2018 Dec;79(6):e119-e120. doi: 10.1016/j.jaad.2018.07.052. Epub 2018 Aug 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Psoriasis*
  • Retrospective Studies
  • Thalidomide* / analogs & derivatives

Substances

  • Thalidomide
  • apremilast